Tavneos 10 mg – DIN 02526662
Tavneos is Avacopan 10 mg (capsule), sold in Canada. It is used for anti-neutrophil cytoplasmic antibody-associated vasculitis. It is supplied by Vifor Fresenius Medical Care Renal Pharma Ltd. We don't have a photo or description of what this pill looks like yet, so check the name and code on the box or bottle, and ask a pharmacist before taking it. Its official Health Canada listing links to the product monograph, which describes the tablets.
Sold in Canada
Avacopan 10 mg
- Brand
- Tavneos
- Strength
- 10 mg
- Used for
- Anti-neutrophil cytoplasmic antibody-associated vasculitis
- Form
- Capsule
- Manufacturer
- Vifor Fresenius Medical Care Renal Pharma Ltd
- Drug class
- Complement 5a receptor antagonist
- Sold in
- Canada
- DIN
- 02526662
Source: Health Canada's Drug Product Database. Last checked .
Report a mistake
What is Avacopan used for?
Avacopan is used for anti-neutrophil cytoplasmic antibody-associated vasculitis.
- Medicine type
- Complement 5a receptor antagonist
Official uses from the US prescribing label
TAVNEOS is indicated as an adjunctive treatment of adult patients with severe active anti-neutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis (granulomatosis with polyangiitis [GPA] and microscopic polyangiitis [MPA]) in combination with standard therapy including glucocorticoids. TAVNEOS does not eliminate glucocorticoid use.
From the FDA-approved label on DailyMed (published Jun 12, 2026).
Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.
Is this your medicine? Check the box
- The box or bottle shows DIN 02526662.
- It names Tavneos, Avacopan 10 mg.
- A loose pill is a different matter: without a description of its markings, a pharmacist has to confirm what it is.
Sold in Canada as Tavneos by Vifor Fresenius Medical Care Renal Pharma Ltd.
In Canada: prescription only.
Ingredients
Active: Avacopan